Strategic Financial Planning Inc. lifted its position in Vanguard FTSE All-World ex-US Small-Cap ETF (NYSEARCA:VSS – Free Report) by 1.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 63,518 shares of the company’s stock after purchasing an additional 1,098 shares during the quarter. Vanguard […]
SAN MATEO, Calif., May 06, 2024 Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional metabolic.